Delos Wealth Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-400
Closed -$39.8K 137
2024
Q4
$39.8K Hold
400
0.03% 81
2024
Q3
$45.4K Sell
400
-36
-8% -$4.28K 0.04% 83
2024
Q2
$54K Hold
436
0.05% 77
2024
Q1
$57.5K Buy
436
+36
+9% +$4.44K 0.06% 67
2023
Q4
$43.6K Sell
400
-20
-5% -$2.08K 0.06% 64
2023
Q3
$45.8K Hold
420
0.06% 73
2023
Q2
$48.5K Hold
420
0.06% 66
2023
Q1
$44.7K Hold
420
0.06% 66
2022
Q4
$46.6K Hold
420
0.07% 61
2022
Q3
$36K Hold
420
0.04% 63
2022
Q2
$38K Hold
420
0.04% 66
2022
Q1
$34K Sell
420
-186
-31% -$14.7K 0.03% 85
2021
Q4
$46K Buy
+606
New +$48.3K 0.04% 81

Other funds holding MRK

Delos Wealth Advisors's MRK Position: Q1 2025 in Review

Delos Wealth Advisors sold out of Merck (MRK) in Q1 2025, closing a stake of 400 shares — an estimated $39.8K sold.

Delos Wealth Advisors first reported a position in MRK in Q4 2021 and held it in 13 quarters. The position peaked at $57.5K in Q1 2024. 3,447 funds tracked by Wall St. Rank hold MRK as of Q1 2025.

  • Delos Wealth Advisors reported no remaining Merck position as of Q1 2025 after selling out during the quarter.
  • Delos Wealth Advisors sold 400 Merck shares in Q1 2025, an estimated $39.8K.
  • Delos Wealth Advisors first reported a position in Merck in Q4 2021 and held it in 13 quarters.
  • Delos Wealth Advisors's Merck position peaked at $57.5K in Q1 2024.
  • 3,447 funds tracked by Wall St. Rank held Merck as of Q1 2025.

Based on Delos Wealth Advisors's 13F filing for Q1 2025, filed 13 May 2025.